Related Experiment Video
Updated: Oct 24, 2025

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
Published on: September 18, 2014
The Cytosolic DNA-Sensing cGAS-STING Pathway in Liver Diseases
Zhilei Wang1,2,3, Nian Chen3, Zhiyong Li3
1TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Abstract:
Inflammation is regulated by the host and is a protective response activated by the evolutionarily conserved immune system in response to harmful stimuli, such as dead cells or pathogens. cGAS-STING pathway is a vital natural sensor of host immunity that can defend various tissues and organs against pathogenic infection, metabolic syndrome, cellular stress and cancer metastasis. The potential impact of cGAS-STING pathway in hepatic ischemia reperfusion (I/R) injury, alcoholic/non-alcoholic steatohepatitis (ASH), hepatic B virus infection, and other liver diseases has recently attracted widespread attention. In this review, the relationship between cGAS-STING pathway and the pathophysiological mechanisms and progression of liver diseases is summarized. Additionally, we discuss various pharmacological agonists and antagonists of cGAS-STING signaling as novel therapeutics for the treatment of liver diseases. A detailed understanding of mechanisms and biology of this pathway will lay a foundation for the development and clinical application of therapies for related liver diseases.
Insights
The cGAS-STING pathway is crucial for immune defense against liver diseases. Understanding its role and targeting it with drugs offers new therapeutic strategies for liver conditions.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Inflammation is a key immune response to harmful stimuli.
- The cGAS-STING pathway acts as a critical sensor in host immunity, protecting against infections, metabolic disorders, and cancer.
- Emerging research highlights the cGAS-STING pathway's significance in various liver diseases, including ischemia-reperfusion injury and viral hepatitis.
Purpose of the Study:
- To review the intricate relationship between the cGAS-STING pathway and the development and progression of liver diseases.
- To explore the potential of cGAS-STING signaling modulators as therapeutic agents for liver ailments.
Main Methods:
- Literature review focusing on the cGAS-STING pathway's role in liver pathophysiology.
- Analysis of existing and potential pharmacological interventions targeting cGAS-STING signaling.
Main Results:
- The cGAS-STING pathway is implicated in the mechanisms underlying hepatic ischemia reperfusion injury, steatohepatitis, and viral hepatitis.
- Pharmacological agonists and antagonists of cGAS-STING signaling represent promising avenues for novel liver disease treatments.
Conclusions:
- A comprehensive understanding of the cGAS-STING pathway's biology is essential for advancing liver disease therapies.
- Targeting the cGAS-STING pathway holds significant potential for developing innovative treatments for a range of liver conditions.
Related Concept Videos
Cell Specific Gene Expression
GPCRs Regulate Adenylyl Cylase Activity
cAMP-dependent Protein Kinase Pathways
Global Regulatory Systems
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

